National Health Investors, Inc.
NYSE:NHIREIT - Healthcare Facilities
-$0.30 today
- Market cap
- $3.07B
- Beta
- 0.55
- P/E (TTM)
- 22.9
- EPS (TTM)
- $3.07
- Dividend yield
- 5.21%
Volume 0.74M
Average 0.40M
NHI Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
National Health Investors, Inc.NYSE: NHI
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization grows in line with its trailing trend
Q3 FY2026 depreciation & amortization of $25.76M rose 27.4% year over year, ahead of the +25.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 0.8% from the prior quarter. Over 3 fiscal years it compounded at +5.8% a year.
Context
- Depreciation & amortization amounted to 22.2% of revenue in FY2025, up 0.8 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +27.4% holds above the trailing-twelve-month pace of +25.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 83.85M USD
- Year-over-year change
- +17.4%
- 4-year CAGR
- +0.9%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 83.85M | +17.4% |
| FY2024 | 2024-12-31 | 71.44M | +2.1% |
| FY2023 | 2023-12-31 | 69.97M | -1.3% |
| FY2022 | 2022-12-31 | 70.88M | -12.3% |
| FY2021 | 2021-12-31 | 80.8M | — |
Depreciation & Amortization vs competitors
How NHI compares with its peers on the latest reported figures
- NHI's LTM Sep 2026 depreciation & amortization of $98.11M is the 8th largest of the 9 companies compared; the peer median is $174.06M.
- Its year-over-year change of +25.8% is the highest of 9, against a peer median of +7.5%.
- Depreciation & amortization amounts to 21.5% of revenue for NHI, versus a peer median of 22.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.29B | +13.1% | +9.1% | 25.6% | |
| LTM Jun 2026 | $209.43M | +21.7% | -0.1% | 24.4% | |
| LTM Sep 2026 | $180.6M | +21.9% | -25.2% | 1.6% | |
| LTM Jun 2026 | $179.34M | +7.6% | +1.1% | 24.6% | |
| LTM Jun 2026 | $168.77M | +7.4% | +4.5% | 21.5% | |
| LTM Jun 2026 | $168.4M | +6.2% | +2.1% | 35.2% | |
| LTM Sep 2026 | $118.36M | -75.6% | -2.9% | 6.4% | |
| LTM Sep 2026 | $98.11M | +25.8% | +5.8% | 21.5% | |
| LTM Mar 2026 | $62.16M | -22.6% | -30.3% | 5.1% | |
| Peer median (excluding NHI) | $174.06M | +7.5% | +0.5% | 22.9% | |
Competitors are the stored peer set for NHI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 111.97M | 65.5M | 134.38M | 137.99M | 142.18M |
| Depreciation & Amortization | 80.8M | 70.88M | 69.97M | 71.44M | 83.85M |
| Deferred Income Tax | (29.04M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 8.42M | 8.61M | 4.61M | 0 | 0 |
| Change in Working Capital | (438K) | (2.7M) | 3.29M | (2.56M) | 7.26M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 3.35M | 425K | 5.93M | 3.29M | 5.49M |
| Other Working Capital | (3.79M) | (3.12M) | (2.64M) | (5.84M) | 1.77M |
| Other Non-Cash Items | 39.16M | 43.04M | (27.8M) | 1.3M | 6.95M |
| Operating Cash Flow | 210.86M | 185.34M | 184.45M | 208.17M | 240.23M |
| Capital Expenditures | (64K) | (4.63M) | (3.74M) | (15.73M) | (19.97M) |
| Acquisitions (Net) | (187.54M) | 11.74M | 0 | 1.17M | 1.75M |
| Purchases of Investments | (119.12M) | (86.17M) | 0 | (202.61M) | (345.18M) |
| Sales of Investments | 306.65M | 288.17M | 0 | 25.63M | 92.33M |
| Other Investing Activities | 185.34M | (11.17M) | (7.89M) | 0 | 0 |
| Investing Cash Flow | 185.28M | 197.95M | (11.63M) | (191.55M) | (271.07M) |
| Debt Repayment | (199.55M) | (93.39M) | (12.43M) | 7.28M | 14.27M |
| Common Stock Issued | 47.9M | 0 | 0 | 142.39M | 181.53M |
| Common Stock Repurchased | 0 | (151.95M) | 0 | 0 | 0 |
| Dividends Paid | (182.9M) | (161.77M) | (156.24M) | (156.51M) | (169.7M) |
| Other Financing Activities | (68.45M) | 5.86M | (1.05M) | (7.9M) | (2.14M) |
| Financing Cash Flow | (402.99M) | (401.25M) | (169.72M) | (14.74M) | 23.96M |
| Effect of Forex Changes | 0 | 0 | 0 | 57K | 2.21M |
| Net Change in Cash | (6.86M) | (17.97M) | 3.1M | 1.94M | (4.67M) |
| Free Cash Flow | 210.8M | 180.71M | 180.71M | 192.44M | 220.26M |
National Health Investors, Inc.
NYSE:NHI
Intrinsic Alpha fair value
Locked
Current Price
$62.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.